Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,350 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 701-725 of 917 matching filings.

Per page
25
Current page
29
8-K File 001-31326

8-K

Filing date
15 Oct 2012
Reporting date
09 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Oct 2012
Reporting date
08 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Oct 2012
Reporting date
08 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-31326

ANNUAL REPORT

Filing date
28 Sep 2012
Reporting date
30 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

CURRENT REPORT

Filing date
18 Sep 2012
Reporting date
18 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
13 Sep 2012
Reporting date
13 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

CURRENT REPORT

Filing date
10 Sep 2012
Reporting date
10 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
07 Sep 2012
Reporting date
05 Sep 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
27 Aug 2012
Reporting date
22 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
15 Aug 2012
Reporting date
13 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
10 Aug 2012
Reporting date
08 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

CURRENT REPORT

Filing date
30 Jul 2012
Reporting date
30 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-31326

CT ORDER filing

Filing date
02 Jul 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
04 Jun 2012
Reporting date
04 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
18 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 May 2012
Reporting date
16 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-31326

FORM 8-K

Filing date
15 May 2012
Reporting date
15 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-31326

QUARTERLY REPORT FORM 10-Q

Filing date
14 May 2012
Reporting date
31 Mar 2012
Next action
Verify source filing
8-K File 001-31326

8-K

Filing date
01 May 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-56243

SC 13G/A

Filing date
24 Apr 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .